Kenya vs Zambia: HIV/AIDS deaths averted by antiretroviral therapy
Kenya
75,293 deaths
in 2024
Zambia
76,693 deaths
in 2024
Kenya rank
8th
Zambia rank
7th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Kenya
- Zambia
How they compare
Zambia currently reports 76,693 deaths against 75,293 deaths in Kenya, a difference of 1,400 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Zambia ahead.
Kenya ranks 8th and Zambia ranks 7th of 157 countries.
Kenya has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Kenya | Zambia | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 18,197 deaths | 13,774 deaths | 4,423 deaths | Kenya |
| 2010s | 71,552 deaths | 53,855 deaths | 17,697 deaths | Kenya |
| 2020s | 75,330 deaths | 72,723 deaths | 2,607 deaths | Kenya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Kenya or Zambia?
- Zambia, at 76,693 deaths against 75,293 deaths in Kenya as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Kenya and Zambia?
- 1,400 deaths, with Zambia ahead.
- How many years of comparable data are there for Kenya and Zambia?
- 35 years are reported by both, from 1990 to 2024.
- How do Kenya and Zambia rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Kenya ranks 8th and Zambia ranks 7th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.